Le Lézard
Classified in: Health
Subjects: PER, BFA

Aptihealth Appoints Amanda Conway as Chief Growth Officer, Accelerating Strategic Expansion in Healthcare


SARATOGA SPRINGS, N.Y., Sept. 6, 2023 /PRNewswire/ -- Aptihealth, a leading provider of mental health services, proudly announces the appointment of Amanda Conway as their new Chief Growth Officer. In this pivotal role, Amanda will leverage her exceptional track record and strategic prowess to drive the company's growth initiatives within the healthcare industry.

Amanda Conway is a seasoned executive renowned for her impressive results in sales, marketing, and account management. With extensive experience in the healthcare sector, Amanda's career has been marked by the successful development and execution of growth strategies, identification of business opportunities, and the effective orchestration of cross-functional teams, consistently delivering outstanding outcomes.

In her most recent position as Chief Growth Officer at Aduro, Amanda's visionary leadership brought about transformative changes. She masterminded the development and execution of strategic growth plans spanning sales, marketing, and account management. Under her guidance, a new go-to-market strategy was introduced, the sales team was fortified, and a robust pipeline of growth was cultivated. Amanda's restructuring of the Account Management team resulted in heightened focus on retention and revenue expansion, leading to exceptional retention rates and substantial revenue increases from existing clients.

Prior to Aduro, Amand held numerous leadership positions at Talkspace, driving enterprise growth, devising go-to-market strategies, and building high-performing sales teams. Her strategic acumen and scalable process implementation delivered substantial revenue growth and team expansion.

At Healthie, Amanda's role as Director of Growth was instrumental in scaling the business and achieving significant revenue milestones. Her adept management of sales teams, development of go-to-market strategies, and seamless collaboration with cross-functional teams played a pivotal role in propelling revenue from ground zero to an impressive $10 million within a remarkably short timeframe.

"We are delighted to welcome Amanda Conway to the aptihealth family as our new Chief Growth Officer," said Tim Koehler, President and Chief Operating Officer at aptihealth. "Her outstanding leadership, remarkable achievements, and visionary approach are set to drive aptihealth to new heights of growth as we continue on our mission to become the nation's preeminent provider of mental health services."

Amanda Conway's appointment underscores aptihealth's commitment to delivering quality behavioral health services and expanding their footprint in the healthcare industry. Her expertise and strategic vision will play a pivotal role in achieving this mission.

SOURCE aptihealth


These press releases may also interest you

at 15:30
The professional membership group of the American Hospital Association focused on healthcare marketing has enlisted experts from the advertising agency universe and the provider data sector to share insights about the best methods for reaching and...

at 15:20
Team famous for HIV breakthroughs demonstrates both persistent COVID virus and widespread immune activation in long COVID; provides clear targets for treatment Key points: SARS-CoV-2 double-stranded RNA indicative of viral replication was found in...

at 15:05
CloudMD Software & Services Inc. (the "Company" or "CloudMD"), an innovative health services company transforming the delivery of care, is pleased to announce that it has received a final order from the Supreme Court of British Columbia approving...

at 14:57
Workers at Watsonville Community Hospital represented by Teamsters Local 853 have voted unanimously to ratify a collective bargaining agreement. The new three-year contract includes significant wage increases, a strong benefits package with Teamsters...

at 14:55
The global anti-inflammatory therapeutics market size is estimated to grow by USD 38.7 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 6.3% during the forecast period. Increase in off-label use is...

at 14:45
Pulse Biosciences, Inc. (the "Company" or "Pulse Biosciences"), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, announced today the closing of its rights offering and the final results...



News published on and distributed by: